Developing an Accurate Price Model for Personalized Medicines

Randy Vogenberg, PhD, RPh

Video Categories: Pricing

Randy Vogenberg discusses the complexities of developing pricing for personalized medicine products
September 2, 2015

Aspirations for the Launch of Ixazomib

Ixazomib may have the potential for great combinability with other drugs, according to Dixie-Lee Esseltine, MD and George Mulligan, PhD. Combination therapy improves compliance, adherence, and quality of life among patients.

January 20, 2016

The Evolution of Stem Cells and Developing Therapies

Dr Wainberg and Dr Gerson talk about blocking cancer stem cell pathways and how randomized trials using therapies aimed at these pathways.